Global Semi-Solid Dosage Form Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Semi-Solid Dosage Form Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Semi-Solid Dosage Form by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Semi-Solid Dosage Form by Country/Region, 2017, 2022 & 2028

2.2 Semi-Solid Dosage Form Segment by Type

2.2.1 Ointments

2.2.2 Gels

2.2.3 Others

2.3 Semi-Solid Dosage Form Sales by Type

2.3.1 Global Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)

2.3.2 Global Semi-Solid Dosage Form Revenue and Market Share by Type (2017-2022)

2.3.3 Global Semi-Solid Dosage Form Sale Price by Type (2017-2022)

2.4 Semi-Solid Dosage Form Segment by Application

2.4.1 Skin

2.4.2 Nasal Cavity

2.4.3 Vaginal Cavity

2.4.4 Rectal Cavity

2.4.5 Others

2.5 Semi-Solid Dosage Form Sales by Application

2.5.1 Global Semi-Solid Dosage Form Sale Market Share by Application (2017-2022)

2.5.2 Global Semi-Solid Dosage Form Revenue and Market Share by Application (2017-2022)

2.5.3 Global Semi-Solid Dosage Form Sale Price by Application (2017-2022)

3 Global Semi-Solid Dosage Form by Company

3.1 Global Semi-Solid Dosage Form Breakdown Data by Company

3.1.1 Global Semi-Solid Dosage Form Annual Sales by Company (2020-2022)

3.1.2 Global Semi-Solid Dosage Form Sales Market Share by Company (2020-2022)

3.2 Global Semi-Solid Dosage Form Annual Revenue by Company (2020-2022)

3.2.1 Global Semi-Solid Dosage Form Revenue by Company (2020-2022)

3.2.2 Global Semi-Solid Dosage Form Revenue Market Share by Company (2020-2022)

3.3 Global Semi-Solid Dosage Form Sale Price by Company

3.4 Key Manufacturers Semi-Solid Dosage Form Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Semi-Solid Dosage Form Product Location Distribution

3.4.2 Players Semi-Solid Dosage Form Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Semi-Solid Dosage Form by Geographic Region

4.1 World Historic Semi-Solid Dosage Form Market Size by Geographic Region (2017-2022)

4.1.1 Global Semi-Solid Dosage Form Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Semi-Solid Dosage Form Annual Revenue by Geographic Region

4.2 World Historic Semi-Solid Dosage Form Market Size by Country/Region (2017-2022)

4.2.1 Global Semi-Solid Dosage Form Annual Sales by Country/Region (2017-2022)

4.2.2 Global Semi-Solid Dosage Form Annual Revenue by Country/Region

4.3 Americas Semi-Solid Dosage Form Sales Growth

4.4 APAC Semi-Solid Dosage Form Sales Growth

4.5 Europe Semi-Solid Dosage Form Sales Growth

4.6 Middle East & Africa Semi-Solid Dosage Form Sales Growth

5 Americas

5.1 Americas Semi-Solid Dosage Form Sales by Country

5.1.1 Americas Semi-Solid Dosage Form Sales by Country (2017-2022)

5.1.2 Americas Semi-Solid Dosage Form Revenue by Country (2017-2022)

5.2 Americas Semi-Solid Dosage Form Sales by Type

5.3 Americas Semi-Solid Dosage Form Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Semi-Solid Dosage Form Sales by Region

6.1.1 APAC Semi-Solid Dosage Form Sales by Region (2017-2022)

6.1.2 APAC Semi-Solid Dosage Form Revenue by Region (2017-2022)

6.2 APAC Semi-Solid Dosage Form Sales by Type

6.3 APAC Semi-Solid Dosage Form Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Semi-Solid Dosage Form by Country

7.1.1 Europe Semi-Solid Dosage Form Sales by Country (2017-2022)

7.1.2 Europe Semi-Solid Dosage Form Revenue by Country (2017-2022)

7.2 Europe Semi-Solid Dosage Form Sales by Type

7.3 Europe Semi-Solid Dosage Form Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Semi-Solid Dosage Form by Country

8.1.1 Middle East & Africa Semi-Solid Dosage Form Sales by Country (2017-2022)

8.1.2 Middle East & Africa Semi-Solid Dosage Form Revenue by Country (2017-2022)

8.2 Middle East & Africa Semi-Solid Dosage Form Sales by Type

8.3 Middle East & Africa Semi-Solid Dosage Form Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Semi-Solid Dosage Form

10.3 Manufacturing Process Analysis of Semi-Solid Dosage Form

10.4 Industry Chain Structure of Semi-Solid Dosage Form

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Semi-Solid Dosage Form Distributors

11.3 Semi-Solid Dosage Form Customer

12 World Forecast Review for Semi-Solid Dosage Form by Geographic Region

12.1 Global Semi-Solid Dosage Form Market Size Forecast by Region

12.1.1 Global Semi-Solid Dosage Form Forecast by Region (2023-2028)

12.1.2 Global Semi-Solid Dosage Form Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Semi-Solid Dosage Form Forecast by Type

12.7 Global Semi-Solid Dosage Form Forecast by Application

13 Key Players Analysis

13.1 Johnson & Johnson

13.1.1 Johnson & Johnson Company Information

13.1.2 Johnson & Johnson Semi-Solid Dosage Form Product Offered

13.1.3 Johnson & Johnson Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Johnson & Johnson Main Business Overview

13.1.5 Johnson & Johnson Latest Developments

13.2 Merck & Co

13.2.1 Merck & Co Company Information

13.2.2 Merck & Co Semi-Solid Dosage Form Product Offered

13.2.3 Merck & Co Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck & Co Main Business Overview

13.2.5 Merck & Co Latest Developments

13.3 Bayer AG

13.3.1 Bayer AG Company Information

13.3.2 Bayer AG Semi-Solid Dosage Form Product Offered

13.3.3 Bayer AG Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer AG Main Business Overview

13.3.5 Bayer AG Latest Developments

13.4 Hisamitsu Pharmaceutical

13.4.1 Hisamitsu Pharmaceutical Company Information

13.4.2 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product Offered

13.4.3 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hisamitsu Pharmaceutical Main Business Overview

13.4.5 Hisamitsu Pharmaceutical Latest Developments

13.5 Glenmark Pharmaceuticals

13.5.1 Glenmark Pharmaceuticals Company Information

13.5.2 Glenmark Pharmaceuticals Semi-Solid Dosage Form Product Offered

13.5.3 Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Glenmark Pharmaceuticals Main Business Overview

13.5.5 Glenmark Pharmaceuticals Latest Developments

13.6 Cipla Ltd

13.6.1 Cipla Ltd Company Information

13.6.2 Cipla Ltd Semi-Solid Dosage Form Product Offered

13.6.3 Cipla Ltd Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Cipla Ltd Main Business Overview

13.6.5 Cipla Ltd Latest Developments

13.7 Nestlé SA

13.7.1 Nestlé SA Company Information

13.7.2 Nestlé SA Semi-Solid Dosage Form Product Offered

13.7.3 Nestlé SA Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Nestlé SA Main Business Overview

13.7.5 Nestlé SA Latest Developments

13.8 Novartis AG

13.8.1 Novartis AG Company Information

13.8.2 Novartis AG Semi-Solid Dosage Form Product Offered

13.8.3 Novartis AG Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novartis AG Main Business Overview

13.8.5 Novartis AG Latest Developments

13.9 GlaxoSmithKline plc

13.9.1 GlaxoSmithKline plc Company Information

13.9.2 GlaxoSmithKline plc Semi-Solid Dosage Form Product Offered

13.9.3 GlaxoSmithKline plc Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GlaxoSmithKline plc Main Business Overview

13.9.5 GlaxoSmithKline plc Latest Developments

13.10 Bausch Health Companies

13.10.1 Bausch Health Companies Company Information

13.10.2 Bausch Health Companies Semi-Solid Dosage Form Product Offered

13.10.3 Bausch Health Companies Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Bausch Health Companies Main Business Overview

13.10.5 Bausch Health Companies Latest Developments

13.11 Allergan plc

13.11.1 Allergan plc Company Information

13.11.2 Allergan plc Semi-Solid Dosage Form Product Offered

13.11.3 Allergan plc Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Allergan plc Main Business Overview

13.11.5 Allergan plc Latest Developments

13.12 Biofrontera, Inc.

13.12.1 Biofrontera, Inc. Company Information

13.12.2 Biofrontera, Inc. Semi-Solid Dosage Form Product Offered

13.12.3 Biofrontera, Inc. Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Biofrontera, Inc. Main Business Overview

13.12.5 Biofrontera, Inc. Latest Developments

13.13 Crown Laboratories Inc.

13.13.1 Crown Laboratories Inc. Company Information

13.13.2 Crown Laboratories Inc. Semi-Solid Dosage Form Product Offered

13.13.3 Crown Laboratories Inc. Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Crown Laboratories Inc. Main Business Overview

13.13.5 Crown Laboratories Inc. Latest Developments

13.14 Akorn Inc. (US)

13.14.1 Akorn Inc. (US) Company Information

13.14.2 Akorn Inc. (US) Semi-Solid Dosage Form Product Offered

13.14.3 Akorn Inc. (US) Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Akorn Inc. (US) Main Business Overview

13.14.5 Akorn Inc. (US) Latest Developments

13.15 Ingenus Pharmaceuticals

13.15.1 Ingenus Pharmaceuticals Company Information

13.15.2 Ingenus Pharmaceuticals Semi-Solid Dosage Form Product Offered

13.15.3 Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Ingenus Pharmaceuticals Main Business Overview

13.15.5 Ingenus Pharmaceuticals Latest Developments

13.16 Sun Pharmaceuticals

13.16.1 Sun Pharmaceuticals Company Information

13.16.2 Sun Pharmaceuticals Semi-Solid Dosage Form Product Offered

13.16.3 Sun Pharmaceuticals Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sun Pharmaceuticals Main Business Overview

13.16.5 Sun Pharmaceuticals Latest Developments

13.17 Crescita Therapeutics Inc.

13.17.1 Crescita Therapeutics Inc. Company Information

13.17.2 Crescita Therapeutics Inc. Semi-Solid Dosage Form Product Offered

13.17.3 Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Crescita Therapeutics Inc. Main Business Overview

13.17.5 Crescita Therapeutics Inc. Latest Developments

13.18 Mylan N.V.

13.18.1 Mylan N.V. Company Information

13.18.2 Mylan N.V. Semi-Solid Dosage Form Product Offered

13.18.3 Mylan N.V. Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Mylan N.V. Main Business Overview

13.18.5 Mylan N.V. Latest Developments

13.19 Encore Dermatology, Inc.

13.19.1 Encore Dermatology, Inc. Company Information

13.19.2 Encore Dermatology, Inc. Semi-Solid Dosage Form Product Offered

13.19.3 Encore Dermatology, Inc. Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Encore Dermatology, Inc. Main Business Overview

13.19.5 Encore Dermatology, Inc. Latest Developments

13.20 LEO Pharma

13.20.1 LEO Pharma Company Information

13.20.2 LEO Pharma Semi-Solid Dosage Form Product Offered

13.20.3 LEO Pharma Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 LEO Pharma Main Business Overview

13.20.5 LEO Pharma Latest Developments

13.21 Almirall, S.A

13.21.1 Almirall, S.A Company Information

13.21.2 Almirall, S.A Semi-Solid Dosage Form Product Offered

13.21.3 Almirall, S.A Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Almirall, S.A Main Business Overview

13.21.5 Almirall, S.A Latest Developments

13.22 Aclaris Therapeutics, Inc.

13.22.1 Aclaris Therapeutics, Inc. Company Information

13.22.2 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product Offered

13.22.3 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Aclaris Therapeutics, Inc. Main Business Overview

13.22.5 Aclaris Therapeutics, Inc. Latest Developments

13.23 Taro Pharmaceutical Industries Ltd.

13.23.1 Taro Pharmaceutical Industries Ltd. Company Information

13.23.2 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product Offered

13.23.3 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Taro Pharmaceutical Industries Ltd. Main Business Overview

13.23.5 Taro Pharmaceutical Industries Ltd. Latest Developments

13.24 Teligent Pharma

13.24.1 Teligent Pharma Company Information

13.24.2 Teligent Pharma Semi-Solid Dosage Form Product Offered

13.24.3 Teligent Pharma Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Teligent Pharma Main Business Overview

13.24.5 Teligent Pharma Latest Developments

13.25 Perrigo Pharma

13.25.1 Perrigo Pharma Company Information

13.25.2 Perrigo Pharma Semi-Solid Dosage Form Product Offered

13.25.3 Perrigo Pharma Semi-Solid Dosage Form Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Perrigo Pharma Main Business Overview

13.25.5 Perrigo Pharma Latest Developments

14 Research Findings and Conclusion

Table 1. Semi-Solid Dosage Form Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Semi-Solid Dosage Form Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Ointments

Table 4. Major Players of Gels

Table 5. Major Players of Others

Table 6. Global Semi-Solid Dosage Form Sales by Type (2017-2022) & (K Units)

Table 7. Global Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)

Table 8. Global Semi-Solid Dosage Form Revenue by Type (2017-2022) & ($ million)

Table 9. Global Semi-Solid Dosage Form Revenue Market Share by Type (2017-2022)

Table 10. Global Semi-Solid Dosage Form Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Semi-Solid Dosage Form Sales by Application (2017-2022) & (K Units)

Table 12. Global Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)

Table 13. Global Semi-Solid Dosage Form Revenue by Application (2017-2022)

Table 14. Global Semi-Solid Dosage Form Revenue Market Share by Application (2017-2022)

Table 15. Global Semi-Solid Dosage Form Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Semi-Solid Dosage Form Sales by Company (2020-2022) & (K Units)

Table 17. Global Semi-Solid Dosage Form Sales Market Share by Company (2020-2022)

Table 18. Global Semi-Solid Dosage Form Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Semi-Solid Dosage Form Revenue Market Share by Company (2020-2022)

Table 20. Global Semi-Solid Dosage Form Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Semi-Solid Dosage Form Producing Area Distribution and Sales Area

Table 22. Players Semi-Solid Dosage Form Products Offered

Table 23. Semi-Solid Dosage Form Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Semi-Solid Dosage Form Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Semi-Solid Dosage Form Sales Market Share Geographic Region (2017-2022)

Table 28. Global Semi-Solid Dosage Form Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Semi-Solid Dosage Form Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Semi-Solid Dosage Form Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Semi-Solid Dosage Form Sales Market Share by Country/Region (2017-2022)

Table 32. Global Semi-Solid Dosage Form Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Semi-Solid Dosage Form Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Semi-Solid Dosage Form Sales by Country (2017-2022) & (K Units)

Table 35. Americas Semi-Solid Dosage Form Sales Market Share by Country (2017-2022)

Table 36. Americas Semi-Solid Dosage Form Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Semi-Solid Dosage Form Revenue Market Share by Country (2017-2022)

Table 38. Americas Semi-Solid Dosage Form Sales by Type (2017-2022) & (K Units)

Table 39. Americas Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)

Table 40. Americas Semi-Solid Dosage Form Sales by Application (2017-2022) & (K Units)

Table 41. Americas Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)

Table 42. APAC Semi-Solid Dosage Form Sales by Region (2017-2022) & (K Units)

Table 43. APAC Semi-Solid Dosage Form Sales Market Share by Region (2017-2022)

Table 44. APAC Semi-Solid Dosage Form Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Semi-Solid Dosage Form Revenue Market Share by Region (2017-2022)

Table 46. APAC Semi-Solid Dosage Form Sales by Type (2017-2022) & (K Units)

Table 47. APAC Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)

Table 48. APAC Semi-Solid Dosage Form Sales by Application (2017-2022) & (K Units)

Table 49. APAC Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)

Table 50. Europe Semi-Solid Dosage Form Sales by Country (2017-2022) & (K Units)

Table 51. Europe Semi-Solid Dosage Form Sales Market Share by Country (2017-2022)

Table 52. Europe Semi-Solid Dosage Form Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Semi-Solid Dosage Form Revenue Market Share by Country (2017-2022)

Table 54. Europe Semi-Solid Dosage Form Sales by Type (2017-2022) & (K Units)

Table 55. Europe Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)

Table 56. Europe Semi-Solid Dosage Form Sales by Application (2017-2022) & (K Units)

Table 57. Europe Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Semi-Solid Dosage Form Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Semi-Solid Dosage Form Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Semi-Solid Dosage Form Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Semi-Solid Dosage Form Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Semi-Solid Dosage Form Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Semi-Solid Dosage Form Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Semi-Solid Dosage Form Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Semi-Solid Dosage Form

Table 67. Key Market Challenges & Risks of Semi-Solid Dosage Form

Table 68. Key Industry Trends of Semi-Solid Dosage Form

Table 69. Semi-Solid Dosage Form Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Semi-Solid Dosage Form Distributors List

Table 72. Semi-Solid Dosage Form Customer List

Table 73. Global Semi-Solid Dosage Form Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Semi-Solid Dosage Form Sales Market Forecast by Region

Table 75. Global Semi-Solid Dosage Form Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Semi-Solid Dosage Form Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Semi-Solid Dosage Form Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Semi-Solid Dosage Form Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Semi-Solid Dosage Form Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Semi-Solid Dosage Form Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Semi-Solid Dosage Form Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Semi-Solid Dosage Form Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Semi-Solid Dosage Form Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Semi-Solid Dosage Form Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Semi-Solid Dosage Form Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Semi-Solid Dosage Form Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Semi-Solid Dosage Form Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Semi-Solid Dosage Form Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Semi-Solid Dosage Form Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Semi-Solid Dosage Form Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Semi-Solid Dosage Form Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Semi-Solid Dosage Form Revenue Market Share Forecast by Application (2023-2028)

Table 93. Johnson & Johnson Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 94. Johnson & Johnson Semi-Solid Dosage Form Product Offered

Table 95. Johnson & Johnson Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Johnson & Johnson Main Business

Table 97. Johnson & Johnson Latest Developments

Table 98. Merck & Co Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 99. Merck & Co Semi-Solid Dosage Form Product Offered

Table 100. Merck & Co Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Merck & Co Main Business

Table 102. Merck & Co Latest Developments

Table 103. Bayer AG Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 104. Bayer AG Semi-Solid Dosage Form Product Offered

Table 105. Bayer AG Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Bayer AG Main Business

Table 107. Bayer AG Latest Developments

Table 108. Hisamitsu Pharmaceutical Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 109. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product Offered

Table 110. Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Hisamitsu Pharmaceutical Main Business

Table 112. Hisamitsu Pharmaceutical Latest Developments

Table 113. Glenmark Pharmaceuticals Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 114. Glenmark Pharmaceuticals Semi-Solid Dosage Form Product Offered

Table 115. Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Glenmark Pharmaceuticals Main Business

Table 117. Glenmark Pharmaceuticals Latest Developments

Table 118. Cipla Ltd Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 119. Cipla Ltd Semi-Solid Dosage Form Product Offered

Table 120. Cipla Ltd Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Cipla Ltd Main Business

Table 122. Cipla Ltd Latest Developments

Table 123. Nestlé SA Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 124. Nestlé SA Semi-Solid Dosage Form Product Offered

Table 125. Nestlé SA Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Nestlé SA Main Business

Table 127. Nestlé SA Latest Developments

Table 128. Novartis AG Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 129. Novartis AG Semi-Solid Dosage Form Product Offered

Table 130. Novartis AG Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Novartis AG Main Business

Table 132. Novartis AG Latest Developments

Table 133. GlaxoSmithKline plc Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 134. GlaxoSmithKline plc Semi-Solid Dosage Form Product Offered

Table 135. GlaxoSmithKline plc Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. GlaxoSmithKline plc Main Business

Table 137. GlaxoSmithKline plc Latest Developments

Table 138. Bausch Health Companies Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 139. Bausch Health Companies Semi-Solid Dosage Form Product Offered

Table 140. Bausch Health Companies Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Bausch Health Companies Main Business

Table 142. Bausch Health Companies Latest Developments

Table 143. Allergan plc Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 144. Allergan plc Semi-Solid Dosage Form Product Offered

Table 145. Allergan plc Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Allergan plc Main Business

Table 147. Allergan plc Latest Developments

Table 148. Biofrontera, Inc. Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 149. Biofrontera, Inc. Semi-Solid Dosage Form Product Offered

Table 150. Biofrontera, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Biofrontera, Inc. Main Business

Table 152. Biofrontera, Inc. Latest Developments

Table 153. Crown Laboratories Inc. Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 154. Crown Laboratories Inc. Semi-Solid Dosage Form Product Offered

Table 155. Crown Laboratories Inc. Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Crown Laboratories Inc. Main Business

Table 157. Crown Laboratories Inc. Latest Developments

Table 158. Akorn Inc. (US) Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 159. Akorn Inc. (US) Semi-Solid Dosage Form Product Offered

Table 160. Akorn Inc. (US) Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Akorn Inc. (US) Main Business

Table 162. Akorn Inc. (US) Latest Developments

Table 163. Ingenus Pharmaceuticals Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 164. Ingenus Pharmaceuticals Semi-Solid Dosage Form Product Offered

Table 165. Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Ingenus Pharmaceuticals Main Business

Table 167. Ingenus Pharmaceuticals Latest Developments

Table 168. Sun Pharmaceuticals Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 169. Sun Pharmaceuticals Semi-Solid Dosage Form Product Offered

Table 170. Sun Pharmaceuticals Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. Sun Pharmaceuticals Main Business

Table 172. Sun Pharmaceuticals Latest Developments

Table 173. Crescita Therapeutics Inc. Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 174. Crescita Therapeutics Inc. Semi-Solid Dosage Form Product Offered

Table 175. Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 176. Crescita Therapeutics Inc. Main Business

Table 177. Crescita Therapeutics Inc. Latest Developments

Table 178. Mylan N.V. Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 179. Mylan N.V. Semi-Solid Dosage Form Product Offered

Table 180. Mylan N.V. Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 181. Mylan N.V. Main Business

Table 182. Mylan N.V. Latest Developments

Table 183. Encore Dermatology, Inc. Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 184. Encore Dermatology, Inc. Semi-Solid Dosage Form Product Offered

Table 185. Encore Dermatology, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 186. Encore Dermatology, Inc. Main Business

Table 187. Encore Dermatology, Inc. Latest Developments

Table 188. LEO Pharma Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 189. LEO Pharma Semi-Solid Dosage Form Product Offered

Table 190. LEO Pharma Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 191. LEO Pharma Main Business

Table 192. LEO Pharma Latest Developments

Table 193. Almirall, S.A Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 194. Almirall, S.A Semi-Solid Dosage Form Product Offered

Table 195. Almirall, S.A Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 196. Almirall, S.A Main Business

Table 197. Almirall, S.A Latest Developments

Table 198. Aclaris Therapeutics, Inc. Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 199. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product Offered

Table 200. Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 201. Aclaris Therapeutics, Inc. Main Business

Table 202. Aclaris Therapeutics, Inc. Latest Developments

Table 203. Taro Pharmaceutical Industries Ltd. Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 204. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product Offered

Table 205. Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 206. Taro Pharmaceutical Industries Ltd. Main Business

Table 207. Taro Pharmaceutical Industries Ltd. Latest Developments

Table 208. Teligent Pharma Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 209. Teligent Pharma Semi-Solid Dosage Form Product Offered

Table 210. Teligent Pharma Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 211. Teligent Pharma Main Business

Table 212. Teligent Pharma Latest Developments

Table 213. Perrigo Pharma Basic Information, Semi-Solid Dosage Form Manufacturing Base, Sales Area and Its Competitors

Table 214. Perrigo Pharma Semi-Solid Dosage Form Product Offered

Table 215. Perrigo Pharma Semi-Solid Dosage Form Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 216. Perrigo Pharma Main Business

Table 217. Perrigo Pharma Latest Developments

List of Figures

Figure 1. Picture of Semi-Solid Dosage Form

Figure 2. Semi-Solid Dosage Form Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Semi-Solid Dosage Form Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Semi-Solid Dosage Form Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Semi-Solid Dosage Form Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Ointments

Figure 10. Product Picture of Gels

Figure 11. Product Picture of Others

Figure 12. Global Semi-Solid Dosage Form Sales Market Share by Type in 2021

Figure 13. Global Semi-Solid Dosage Form Revenue Market Share by Type (2017-2022)

Figure 14. Semi-Solid Dosage Form Consumed in Skin

Figure 15. Global Semi-Solid Dosage Form Market: Skin (2017-2022) & (K Units)

Figure 16. Semi-Solid Dosage Form Consumed in Nasal Cavity

Figure 17. Global Semi-Solid Dosage Form Market: Nasal Cavity (2017-2022) & (K Units)

Figure 18. Semi-Solid Dosage Form Consumed in Vaginal Cavity

Figure 19. Global Semi-Solid Dosage Form Market: Vaginal Cavity (2017-2022) & (K Units)

Figure 20. Semi-Solid Dosage Form Consumed in Rectal Cavity

Figure 21. Global Semi-Solid Dosage Form Market: Rectal Cavity (2017-2022) & (K Units)

Figure 22. Semi-Solid Dosage Form Consumed in Others

Figure 23. Global Semi-Solid Dosage Form Market: Others (2017-2022) & (K Units)

Figure 24. Global Semi-Solid Dosage Form Sales Market Share by Application (2017-2022)

Figure 25. Global Semi-Solid Dosage Form Revenue Market Share by Application in 2021

Figure 26. Semi-Solid Dosage Form Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Semi-Solid Dosage Form Revenue Market Share by Company in 2021

Figure 28. Global Semi-Solid Dosage Form Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Semi-Solid Dosage Form Revenue Market Share by Geographic Region in 2021

Figure 30. Global Semi-Solid Dosage Form Sales Market Share by Region (2017-2022)

Figure 31. Global Semi-Solid Dosage Form Revenue Market Share by Country/Region in 2021

Figure 32. Americas Semi-Solid Dosage Form Sales 2017-2022 (K Units)

Figure 33. Americas Semi-Solid Dosage Form Revenue 2017-2022 ($ Millions)

Figure 34. APAC Semi-Solid Dosage Form Sales 2017-2022 (K Units)

Figure 35. APAC Semi-Solid Dosage Form Revenue 2017-2022 ($ Millions)

Figure 36. Europe Semi-Solid Dosage Form Sales 2017-2022 (K Units)

Figure 37. Europe Semi-Solid Dosage Form Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Semi-Solid Dosage Form Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Semi-Solid Dosage Form Revenue 2017-2022 ($ Millions)

Figure 40. Americas Semi-Solid Dosage Form Sales Market Share by Country in 2021

Figure 41. Americas Semi-Solid Dosage Form Revenue Market Share by Country in 2021

Figure 42. United States Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Semi-Solid Dosage Form Sales Market Share by Region in 2021

Figure 47. APAC Semi-Solid Dosage Form Revenue Market Share by Regions in 2021

Figure 48. China Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Semi-Solid Dosage Form Sales Market Share by Country in 2021

Figure 55. Europe Semi-Solid Dosage Form Revenue Market Share by Country in 2021

Figure 56. Germany Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Semi-Solid Dosage Form Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Semi-Solid Dosage Form Revenue Market Share by Country in 2021

Figure 63. Egypt Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Semi-Solid Dosage Form Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Semi-Solid Dosage Form in 2021

Figure 69. Manufacturing Process Analysis of Semi-Solid Dosage Form

Figure 70. Industry Chain Structure of Semi-Solid Dosage Form

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles